Top compounds associated with response to HNRNPCL4


Feature Type Standardized
Nominal ANOVA
mRNA ciclosporin CTRPv2 pan-cancer AAC 0.066 0.07
mRNA AZD1480 CTRPv2 pan-cancer AAC -0.093 0.07
mRNA Curcumin CTRPv2 pan-cancer AAC 0.059 0.08
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.056 0.08
mRNA Vandetanib CTRPv2 pan-cancer AAC -0.062 0.08
mRNA pifithrin-mu CTRPv2 pan-cancer AAC 0.059 0.08
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.058 0.08
mRNA clofarabine CTRPv2 pan-cancer AAC -0.049 0.08
mRNA RAF265 CTRPv2 pan-cancer AAC 0.068 0.09
mRNA salermide CTRPv2 pan-cancer AAC -0.074 0.09
Download CSV